Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04JWR
|
|||
| Drug Name |
PMID29671355-Compound-36
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
UNIVERSITE PARIS-SUD CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histone deacetylase 11 (HDAC11) | Target Info | Inhibitor | [1] |
| Histone deacetylase 8 (HDAC8) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Histone deacetylase 11 (HDAC11) | Target's Patent Info | [1] | |
| Histone deacetylase 8 (HDAC8) | Target's Patent Info | [1] | ||
| KEGG Pathway | Alcoholism | |||
| Viral carcinogenesis | ||||
| Panther Pathway | Wnt signaling pathway | |||
| Pathway Interaction Database | Signaling events mediated by HDAC Class I | |||
| Reactome | NOTCH1 Intracellular Domain Regulates Transcription | |||
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | ||||
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | ||||
| HDACs deacetylate histones | ||||
| WikiPathways | Integrated Pancreatic Cancer Pathway | |||
| Neural Crest Differentiation | ||||
| Cell Cycle | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.